Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Michaut

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cell Reports|December 3, 2014
Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibitionPatricia A Possik, Judith Müller, Carmen Gerlach, et al.
European Urology|February 1, 2015
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant ChemotherapyFloris H Groenendijk, Jeroen de Jong, Elisabeth E Fransen van de Putte, et al.
Breast Cancer Research : BCR|August 31, 2017
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingTesa M Severson, Denise M Wolf, Christina Yau, et al.
Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Cell Reports|May 11, 2022
PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituentsMatilda Rehn, Anne Wenzel, Anne-Katrine Frank, et al.
Plos One|July 9, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 geneLorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, et al.
Plos Genetics|November 30, 2011
Genetic interaction maps in Escherichia coli reveal functional crosstalk among cell envelope biogenesis pathwaysMohan Babu, J Javier Díaz-Mejía, James Vlasblom, et al.
Cell Reports|August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer CellsTheodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Oncoimmunology|December 8, 2018
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survivalMarcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cell Reports|December 3, 2014
Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibitionPatricia A Possik, Judith Müller, Carmen Gerlach, et al.
European Urology|February 1, 2015
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant ChemotherapyFloris H Groenendijk, Jeroen de Jong, Elisabeth E Fransen van de Putte, et al.
Breast Cancer Research : BCR|August 31, 2017
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingTesa M Severson, Denise M Wolf, Christina Yau, et al.
Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Cell Reports|May 11, 2022
PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituentsMatilda Rehn, Anne Wenzel, Anne-Katrine Frank, et al.
Plos One|July 9, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 geneLorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, et al.
Plos Genetics|November 30, 2011
Genetic interaction maps in Escherichia coli reveal functional crosstalk among cell envelope biogenesis pathwaysMohan Babu, J Javier Díaz-Mejía, James Vlasblom, et al.
Cell Reports|August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer CellsTheodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Oncoimmunology|December 8, 2018
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survivalMarcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, et al.
Pageof 5